The features of SONDELBAY® and its pen were selected
with patients in mind1,2

SONDELBAY® offers people with osteoporosis a small and light-weight
device for self-injecting teriparatide, designed to be easy to handle:2

  • Compact and light-weight pen2
  • Side injection button3
  • Visible dose counter3
  • No priming needed3
  • No removing and replacing of cartridges3
  • Clear view of the drug solution in the pen once the pen cap is removed3
  • Maximum 3 days out-of-fridge stability at temperatures up to 25°C1
    1. In-use stability demonstrated for 28 days at 2–8°C. Within the 28 days, the product can be stored at temperature conditions up to 25°C for a maximum of 3 days. Once opened, it may be stored for a maximum of 28 days at the above temperature conditions1
References:

1.SONDELBAY® Summary of Product Characteristics. 2. Data on file – UK-03873 (March 2022). Sondelbay Product Details.

3.SONDELBAY® Instructions for use.

SONDELBAY® (teriparatide) Summary of Product Characteristics (SmPC), legal category, cost and adverse event reporting:
Legal Category POM: Prescription only medicine
NHS list prices:
1 Pen: £271.87
3 Pens: £815.61
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Accord-UK LTD on 01271 385257 or email medinfo@accord-healthcare.com
  • © Copyright Accord-UK 2025
  • UK-04004
  • Date of preparation: April 2025